Clinical Trials Directory

Trials / Completed

CompletedNCT01387568

Lidocaine Infusion for Major Abdominal Pediatric Surgery

The Effects of Intravenous Lidocaine Infusion During and After Major Abdominal Pediatric Surgery. A Randomized Double-blinded Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
1 Year – 6 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators hypothesized that perioperative i.v. infusion of lidocaine in major abdominal pediatric surgery, may have a beneficial effect on hemodynamic and hormonal responses. Also, it could decrease the hospital stay, opioid requirement and hasten return of bowel function.

Detailed description

The inflammatory response after major abdominal surgery is of great importance for patients, physicians and perioperative medicine1. Perioperative excessive stimulation of the inflammatory and hemostatic systems may result in development of postoperative ileus, ischemia-reperfusion syndromes, hypercoagulation syndromes (e.g. deep venous thrombosis) and pain excessive inflammatory response such as impaired gastrointestinal motility, so modulation of inflammatory responses may decrease severity of such complications 2,3. Intravenous lidocaine, a local anesthetic, has been shown to improve postoperative analgesia, reduce postoperative opioid requirements, accelerate postoperative recovery of bowel function, attenuate postoperative fatigue, reduced the duration of hospitalization, and facilitate acute rehabilitation in patients undergoing laparoscopic abdominal surgery 4. Administration of local anesthetics to epidural space has analgesic effect, blunt stress response; provide rapid mobilization, early extubation with rapid recovery of bowel function 5. However, insertion of an epidural catheter carries risks especially in pediatric populations. So, systemic lidocaine may become another strategy for improving perioperative outcome which is safe and effective2.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine Infusionchildren in group L received i.v. lidocaine 1.5 mg/kg followed by infusion at 1.5 mg. kg-1.h-1. and were continued up to 6 hours postoperatively
DRUGsaline Infusionchildren in group P received i.v. saline 0.9% 1 ml/kg followed by infusion at 0.1 ml. kg-1.h-1,and were continued up to 6 hours postoperatively

Timeline

Start date
2010-03-01
Primary completion
2011-01-01
Completion
2011-02-01
First posted
2011-07-04
Last updated
2012-04-20

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01387568. Inclusion in this directory is not an endorsement.